154 related articles for article (PubMed ID: 36755811)
1. Downregulation of CAMK2N1 due to DNA Hypermethylation Mediated by DNMT1 that Promotes the Progression of Prostate Cancer.
Peng W; Feng H; Pang L; Zhang J; Hao Y; Wei X; Xia Q; Wei Z; Song W; Wang S; Liu J; Chen K; Wang T
J Oncol; 2023; 2023():4539045. PubMed ID: 36755811
[TBL] [Abstract][Full Text] [Related]
2. MTSS1 hypermethylation is associated with prostate cancer progression.
Chen J; Huang L; Zhu Q; Wang Z; Tang Z
J Cell Physiol; 2020 Mar; 235(3):2687-2697. PubMed ID: 31541465
[TBL] [Abstract][Full Text] [Related]
3. MiR-129-5p promotes docetaxel resistance in prostate cancer by down-regulating CAMK2N1 expression.
Wu C; Miao C; Tang Q; Zhou X; Xi P; Chang P; Hua L; Ni H
J Cell Mol Med; 2020 Feb; 24(3):2098-2108. PubMed ID: 31876385
[TBL] [Abstract][Full Text] [Related]
4. DNMT1 Regulates Epithelial-Mesenchymal Transition and Cancer Stem Cells, Which Promotes Prostate Cancer Metastasis.
Lee E; Wang J; Yumoto K; Jung Y; Cackowski FC; Decker AM; Li Y; Franceschi RT; Pienta KJ; Taichman RS
Neoplasia; 2016 Sep; 18(9):553-66. PubMed ID: 27659015
[TBL] [Abstract][Full Text] [Related]
5. Regulation of
Yang X; Wang S; Reheman A
Cancer Manag Res; 2020; 12():6411-6420. PubMed ID: 32801881
[TBL] [Abstract][Full Text] [Related]
6. Expression of EMT-Related Genes CAMK2N1 and WNT5A is increased in Locally Invasive and Metastatic Prostate Cancer.
Carneiro I; Quintela-Vieira F; Lobo J; Moreira-Barbosa C; Menezes FD; Martins AT; Oliveira J; Silva R; Jerónimo C; Henrique R
J Cancer; 2019; 10(24):5915-5925. PubMed ID: 31762801
[No Abstract] [Full Text] [Related]
7. Activation of silenced tumor suppressor genes in prostate cancer cells by a novel energy restriction-mimetic agent.
Lin HY; Kuo YC; Weng YI; Lai IL; Huang TH; Lin SP; Niu DM; Chen CS
Prostate; 2012 Dec; 72(16):1767-78. PubMed ID: 22539223
[TBL] [Abstract][Full Text] [Related]
8. Demethylation of the miR-146a promoter by 5-Aza-2'-deoxycytidine correlates with delayed progression of castration-resistant prostate cancer.
Wang X; Gao H; Ren L; Gu J; Zhang Y; Zhang Y
BMC Cancer; 2014 May; 14():308. PubMed ID: 24885368
[TBL] [Abstract][Full Text] [Related]
9. The circSPON2/miR-331-3p axis regulates PRMT5, an epigenetic regulator of CAMK2N1 transcription and prostate cancer progression.
Yao B; Zhu S; Wei X; Chen MK; Feng Y; Li Z; Xu X; Zhang Y; Wang Y; Zhou J; Tang N; Ji C; Jiang P; Zhao SC; Qin C; Feng N
Mol Cancer; 2022 May; 21(1):119. PubMed ID: 35624451
[TBL] [Abstract][Full Text] [Related]
10. The tumor suppressive role of CAMK2N1 in castration-resistant prostate cancer.
Wang T; Liu Z; Guo S; Wu L; Li M; Yang J; Chen R; Xu H; Cai S; Chen H; Li W; Wang L; Hu Z; Zhuang Q; Xu S; Wang L; Liu J; Ye Z; Ji JY; Wang C; Chen K
Oncotarget; 2014 Jun; 5(11):3611-21. PubMed ID: 25003983
[TBL] [Abstract][Full Text] [Related]
11. CAMK2N1 suppresses hepatoma growth through inhibiting E2F1-mediated cell-cycle signaling.
Peng JM; Tseng RH; Shih TC; Hsieh SY
Cancer Lett; 2021 Jan; 497():66-76. PubMed ID: 33068700
[TBL] [Abstract][Full Text] [Related]
12. DNA methylation paradigm shift: 15-lipoxygenase-1 upregulation in prostatic intraepithelial neoplasia and prostate cancer by atypical promoter hypermethylation.
Kelavkar UP; Harya NS; Hutzley J; Bacich DJ; Monzon FA; Chandran U; Dhir R; O'Keefe DS
Prostaglandins Other Lipid Mediat; 2007 Jan; 82(1-4):185-97. PubMed ID: 17164146
[TBL] [Abstract][Full Text] [Related]
13. Transcriptional repression of SOCS3 mediated by IL-6/STAT3 signaling via DNMT1 promotes pancreatic cancer growth and metastasis.
Huang L; Hu B; Ni J; Wu J; Jiang W; Chen C; Yang L; Zeng Y; Wan R; Hu G; Wang X
J Exp Clin Cancer Res; 2016 Feb; 35():27. PubMed ID: 26847351
[TBL] [Abstract][Full Text] [Related]
14. Tumor suppressor gene inactivation during cadmium-induced malignant transformation of human prostate cells correlates with overexpression of de novo DNA methyltransferase.
Benbrahim-Tallaa L; Waterland RA; Dill AL; Webber MM; Waalkes MP
Environ Health Perspect; 2007 Oct; 115(10):1454-9. PubMed ID: 17938735
[TBL] [Abstract][Full Text] [Related]
15. miR-182-5p Promotes Growth in Oral Squamous Cell Carcinoma by Inhibiting CAMK2N1.
Li N; Nan CC; Zhong XY; Weng JQ; Fan HD; Sun HP; Tang S; Shi L; Huang SX
Cell Physiol Biochem; 2018; 49(4):1329-1341. PubMed ID: 30205384
[TBL] [Abstract][Full Text] [Related]
16. MCM3AP-AS1 KD Inhibits Proliferation, Invasion, and Migration of PCa Cells via DNMT1/DNMT3 (A/B) Methylation-Mediated Upregulation of NPY1R.
Li X; Lv J; Liu S
Mol Ther Nucleic Acids; 2020 Jun; 20():265-278. PubMed ID: 32193153
[TBL] [Abstract][Full Text] [Related]
17. Downregulation of CLDN7 due to promoter hypermethylation is associated with human clear cell renal cell carcinoma progression and poor prognosis.
Li Y; Gong Y; Ning X; Peng D; Liu L; He S; Gong K; Zhang C; Li X; Zhou L
J Exp Clin Cancer Res; 2018 Nov; 37(1):276. PubMed ID: 30428910
[TBL] [Abstract][Full Text] [Related]
18. Calpain-2 triggers prostate cancer metastasis via enhancing CRMP4 promoter methylation through NF-κB/DNMT1 signaling pathway.
Gao X; Mao YH; Xiao C; Li K; Liu W; Li LY; Pang J
Prostate; 2018 Jun; 78(9):682-690. PubMed ID: 29601651
[TBL] [Abstract][Full Text] [Related]
19. Downregulation of DACT-2 by Promoter Methylation and its Clinicopathological Significance in Prostate Cancer.
Li S; Yin L; Huang K; Zhao Y; Zhang H; Cai C; Xu Y; Huang L; Wang X; Lan T; Li H; Ma P
J Cancer; 2019; 10(7):1755-1763. PubMed ID: 31205531
[No Abstract] [Full Text] [Related]
20. FAM107A Inactivation Associated with Promoter Methylation Affects Prostate Cancer Progression through the FAK/PI3K/AKT Pathway.
Ke S; Liu Z; Wang Q; Zhai G; Shao H; Yu X; Guo J
Cancers (Basel); 2022 Aug; 14(16):. PubMed ID: 36010909
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
